Complications of Cancer Chemotherapy:Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973

图书简介

G. MATHE and R. K. OLDHAM’~ Institut de Cancerologie et d’Immunogem!tique, Hopital Paul Brousse, Villejuif Since the last war, cancer chemotherapy has been the object of very intensive and expensive research. Nevertheless, its development has been very slow, and its ultimate potential is today somewhat in doubt. In doubt because it does not cure any cancer patients except a) females carrying placental choriocarcinoma, a semi-allogenic tumor, in which case, cure may be in fluenced by immune rejection, and b) children suffering from Burkitt’s tumor, where the probable reason for the cure is that all the neoplastic cells are in the cycle, which is a unique condition among all the human tumor varieties. Whether the long term survivors in acute leukemia, lymphomas, certain sarcomas and certain testicular tumors are ’cures’ will require longer follow-up. The idea that chemotherapy does not cure most cancer patients because all their neoplastic cells are not in cycle has led to the use of drug combinations. Whatever they are, ’cocktail combinations’ which are made up of drugs given according to any timing, or scientific combinations, based on pharmacodynamics, pharmaco kinetics or cell kinetics data, are more toxic than single drugs, and are all the more toxic as the number of drugs in the combination is increased.

Application of Large Animal Toxicology to the Qualitative and Quantitative Prediction of Drug Toxicity in Man.- Hematological Toxicity: Biological Basis.- Immunological Toxicity of Cancer Chemotherapy.- Bacterial and Fungal Infections During Cancer Chemotherapy.- A Study of Viral Infections in Patients Treated with a Combination of 6 Mercaptopurine-Methotrexate: Preliminary Results.- Role of Gnotobiotic Care in Chemotherapy of Acute Leukemia.- White Blood Cell Transfusions in Leukemic Patients with Severe Infections.- Efficacy of Platelet Transfusions from HL-A Compatible Unrelated Donors to Alloimmunized Patients.- Immune Responsiveness in Acute Lymphocytic Leukemia Patients under Chemotherapy and Immunotherapy: A Preliminary Report.- Transfer Factor Therapy in Immunodeficiencies.- Reconstitution of Cellular Immunity in Hodgkin’s Disease with Transfer Factor.- Complications of Cancer Chemotherapy. The Special Case of Hormones.- Factors Modifying the Activity and Toxicity of Anticancer Agents.- Modification of Drug Metabolism Induced in the Host by the Presence of a Tumor.- IS Local Chemotherapy Less Toxic than Systemic?.- Pharmacokinetic Simulation: A Future Means for Better Control of Cancer Chemotherapy.- Carcinogenesis by Cancer Chemotherapeutic Agents: Second Malignancies Complicating Hodgkin’s Disease in Remission.- Malignancies Possibly Secondary to Anticancer Therapy.- Prevention of Chemotherapy Complications: Time, Toxicity, Pharmacokinetic, Pharmacodynamic and Logistic Factors.

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Complications of Cancer Chemotherapy:Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973（Recent Results in Cancer Research） 临床诊断学

Complications of Cancer Chemotherapy:Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973（Recent Results in Cancer Research）
临床诊断学